BCL2 and neoplasm: Since Bclaf1 is a H2AX-dependent tumor suppressor [28], high levels of circ-Ccnb1 would bind H2AX and wild-type p53, blocking the tumor suppressing effect of p53 and allowing Bcl2 to bind Bclaf1.